Eli Lilly Opens New Gateway Labs in San Diego

Eli Lilly and Company has officially opened its latest Lilly Gateway Labs (LGL) site in San Diego, California, announced in a press release. This new facility expands Lilly's network of shared innovation hubs designed to support early-stage biotechnology companies by providing lab space and opportunities for collaboration with Lilly scientists.

Located on the One Alexandria Square Megacampus in Torrey Pines, the San Diego site features 82,514 square feet of flexible laboratory and office space. It can accommodate up to 15 life sciences companies and more than 250 employees. The facility offers startups access to wet lab facilities, scientific engagement, and strategic guidance to aid in drug discovery and development.

Lilly Gateway Labs San Diego is the fourth U.S. site, joining two locations in South San Francisco and one in Boston. The model is also expanding globally, with a newly opened site in Beijing. Since the inception of the first Gateway Labs site in 2019, companies based at these labs have raised over $2 billion in capital, supporting the development of more than 50 therapeutics and platforms.